A double bind for cancer

Published by  News archive

On 13th Dec 2022

A patient receiving treatment for cancer.
Getty Images

Hitting two targets at the same time may be the key to stopping the spread of aggressive cancers, according to research from the University of East Anglia and the Quadram Institute.

Researchers found that tumour growth in mice could be stopped by simultaneously targeting two signalling switches that trigger growth of new blood vessels.

Their study points to new approaches for treating cancer in humans.

Without a blood supply to provide oxygen and nutrients, tumours fail to develop larger than a few millimetres. To grow they release signalling proteins that trigger cells to form blood vessels, a process known as angiogenesis.

Disrupting these signalling proteins and the receptors on the cell surface that recognise them has been identified previously as a potential strategy to slow tumour growth, but currently the clinical benefits of such interventions have shown limited success unless supplemented by chemotherapy.

In part, this is because researchers are still unsure of the exact mechanisms by which angiogenesis is controlled, either in a healthy state or in cancer.

Dr Stephen Robinson, from UEA’s School of Biological Sciences, said: “We are hoping this piece of research will inspire others to consider the impact of targeting multiple proteins to achieve a synergistic anti-cancer response. By doing so, we aim to restrict a cancer’s ability to escape therapy.”

The first of a group of signalling proteins called vascular endothelial growth factors (VEGFs) was discovered in 1970, but it wasn’t until the late 1990s that a family of VEGF co-receptors were identified – these were neuropilin-1 and 2.

Co-receptors are proteins that sit on the cell surface where they recognise and bind to signalling proteins. Neuropilin-1 and 2 bind to VEGFs, in addition to a plethora of other proteins, triggering a cascade of signals within the cell to activate angiogenesis. Stopping this process in cancer could therefore prevent tumours developing the complex organisation of blood vessels they need to grow.

Researchers have been trying to do just that, using cell and animal models of cancer to identify compounds that block neuropilin-interactions with VEGF. Indeed, promising candidates targeting neuropilin-1 have already been demonstrated to slow breast cancer progression in mice.

However, to date there have been limited studies targeting both neuropilin-1 and 2 simultaneously.

Dr Christopher Benwell, a Postdoctoral Researcher working with Dr Robinson’s team in the Quadram Institute sought to address this gap in understanding, by studying mice in which the genes for either neuropilin-1 and 2, or both in combination, had been deleted.

They found that in multiple models of cancer, targeting both neuropilin-1 and 2 severely inhibited tumour angiogenesis, cancer growth and metastasis, that is its spread to other secondary sites.

Importantly, the extent of the effect was much greater than when either one of the receptors was targeted individually.

“We are really excited by these results and have started to delve deeper into the ways these receptors can be manipulated to control angiogenesis in different disease states,” said Dr Benwell.

Further studies in cultured cells suggested how this protection works. When both neuropilin receptors are targeted, the VEGF receptor is rapidly destroyed by the cell, which cuts off the angiogenic response at its source.

The study was funded by the Biotechnology and Biological Sciences Research Council, part of UK Research and Innovation, the British Heart Foundation and the Norwich Research Park Doctoral Training Partnership.

‘Endothelial neuropilin-1 and neuropilin-2 are essential 1 for tumour angiogenesis’ is published in the journal Cancer Research Communications, a journal of the American Association for Cancer Research.

Latest News

Hanya Yanagihara. She is wearing a black top and necklaces.
02 Feb 2023

Global literary icon Hanya Yanagihara set to make rare UK appearance at UEA Live

Hanya Yanagihara, author of the million-copy bestseller A Little Life, will be welcomed to the UEA campus in March to discuss her latest novel success – To...

Read more >
The RRS Sir David Attenborough in the Arctic.
01 Feb 2023

RRS Sir David Attenborough begins polar science trials in Antarctica

Researchers from the University of East Anglia have joined the UK’s new polar ship RRS Sir David Attenborough as it begins its polar science trials in Antarctica...

Read more >
A forest fire in the Amazon rainforest.
27 Jan 2023

Human activity has degraded more than a third of remaining Amazon rainforest

The Amazon rainforest has been degraded by a much greater extent than scientists previously believed, according to a new study.

Read more >
A child learning to write the alphabet.
27 Jan 2023

Poor literacy linked to worse mental health worldwide, study shows

Read more >
Are you searching for something?
A child learning to write the alphabet.
27 Jan 2023

Poor literacy linked to worse mental health worldwide, study shows

Read more >
A Vitamin D tablet being held up to the sun.
26 Jan 2023

80-year-old medical mystery that caused baby deaths solved

Researchers at the University of East Anglia have solved an 80-year-old medical mystery that causes kidney damage in children and can be fatal in babies.

Read more >
A loudspeaker at a protest.
23 Jan 2023

There may be more power in the hand of the worker than previously thought

Employers who disproportionately punish striking workers may be acting unlawfully, according to new research from the University of East Anglia.

Read more >
Two bottles of hormones held in a gloved hand.
14 Jan 2023

HRT could ward off Alzheimer’s among at-risk women

Hormone Replacement Therapy (HRT) could help prevent Alzheimer’s Dementia among women at risk of developing the disease – according to University of East Anglia...

Read more >
Photo of Heidi Crisp
01 Jan 2023

HSC apprentice shortlisted for finalist in prestigious awards

Occupational therapist apprentice, Heidi Crisp has been shortlisted as one of three finalist  for Apprentice of the Year in the Norfolk Apprenticeship Awards. 

Read more >
Andy Cammidge
24 Jan 2023

New research grant will investigate novel organic materials

Prof Andy Cammidge (CHE) and colleagues have been awarded £800k from the Engineering and Physical Sciences Research Council to investigate the synthesis of new...

Read more >
James Bevan presenting at UEA. He is wearing glasses, a black jacket and grey trousers.
24 Jan 2023

UEA praised for 'outstanding' work on climate research

Sir James Bevan, Chief Executive of the Environment Agency, praised UEA’s outstanding work on climate research and highlighted the need to focus on climate...

Read more >